Viewing nowCombinationFemoston Conti Tablets (Estradiol Hemihydrate, Didrogesterone)
Estradiol Hemihydrate Micronized 1.03mg · Dydrogesterone 5mg
Tablet · Prescription medication · Combination
Abbott Korea Ltd.

MFDS item code 200209806 · Approved 2002.08.20 · Insurance code 644206590
Relief of estrogen deficiency symptoms post-menopause and prevention of osteoporosis
This medication is used for hormone replacement therapy to relieve symptoms caused by estrogen deficiency in postmenopausal women with a uterus. It also helps prevent osteoporosis in postmenopausal women at risk of fractures.
Take 1 tablet once a day. Take continuously without breaks before and after the intake cycle. Can be taken regardless of meals.
This medication should not be used in children under 18 years old or in pregnant or breastfeeding women. Patients with breast cancer or suspected tumors that react to estrogen or progestogens should not take this medication. It should also not be administered in cases of abnormal genital bleeding, endometrial hyperplasia, thrombosis, heart disease, liver disease, porphyria, cerebrovascular disease, or a predisposition to thrombosis. Patients with genetic conditions such as lactose intolerance should not use this preparation containing this medication. If new symptoms such as worsening liver function, jaundice, migraines, visual disturbances, or hypertension occur, inform a doctor immediately. Patients with a history or family history of thrombosis should use with caution, and measures to prevent thrombosis may be necessary before and after surgery. Diabetic patients should closely monitor their blood sugar levels for one month after taking this medication. Patients with a history of endometriosis, thrombosis, family history of breast cancer, hypertension, liver disease, migraines, autoimmune diseases, seizures, asthma, inner ear disorders, or similar conditions should exercise caution while on this medication. If abnormal bleeding persists, consult a doctor immediately and determine the cause of bleeding, such as endometrial cancer. This medication may increase the risk of breast cancer and endometrial cancer, so regular screenings for breast cancer and endometrial health are required. Hormone replacement therapy should only be initiated when menopausal symptoms affect quality of life, and benefits and risks should be assessed at least once a year. This medication may interact with other drugs, so inform your doctor or pharmacist of all medications or health supplements being taken. Do not take this medication if pregnant or if there is a possibility of pregnancy, and if pregnancy is confirmed during treatment, immediately stop taking it and consult a doctor. Overdosage may lead to symptoms such as nausea, vomiting, breast tenderness, dizziness, etc., and this should also be reported to healthcare professionals immediately. This medication does not significantly impact driving or operating machinery, but caution is advised as effects may vary by individual.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blistering, skin peeling, pain in mouth/eye mucosa, shortness of breath or difficulty breathing, asthmatic attacks, cough with fever, jaundice (yellowing of skin or eyes), excessive drowsiness, sudden and severe headache, lightning headache, seizures, confusion, visual disturbances, paralysis, urination
Headache, abdominal pain, breast pain, breast tenderness, back pain, nausea, vomiting, abdominal bloating, dyspepsia, migraine, depression, irritability, dizziness, changes in libido, gallbladder disorders, changes in liver function tests, breast enlargement, skin allergic reactions (rash, itching), purpura, vaginal candidiasis, menstrual disorders, pelvic pain, changes in discharge, symptoms similar to premenstrual syndrome, symptoms similar to cystitis, hypertension, peripheral vascular disease, varicose veins, weight gain, muscle weakness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture, and it is best kept at room temperature between 1°C and 30°C. This storage helps maintain the medication's effectiveness and prevents deterioration.
Peach-colored, round, double-convex film-coated tablet
28 Tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEstradiol Hemihydrate Micronized 1.03mg · Dydrogesterone 5mg
Tablet · Prescription medication · Combination
Abbott Korea Ltd.
CombinationEstradiol Hemihydrate Micronized 2.06mg · Dydrogesterone 10mg
Tablet · Prescription medication · Combination
Abbott Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.